AI assistant
Sending…
BIOGEN INC. — Director's Dealing 2022
Jun 17, 2022
30291_dirs_2022-06-17_5bf5fdde-c19d-49c0-8e54-63eb450fa371.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOGEN INC. (BIIB)
CIK: 0000875045
Period of Report: 2022-06-15
Reporting Person: PAPADOPOULOS STELIOS (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-06-15 | Common Stock | A | 2255 | — | Acquired | 10095 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 10831 | Indirect |
| Common Stock | 17375 | Indirect |
More from BIOGEN INC.
Regulatory Filings
2026
May 14
Major Shareholding Notification
2026
May 6
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 29
Regulatory Filings
2026
Apr 29
Annual Report
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 28
Major Shareholding Notification
2026
Apr 7
Regulatory Filings
2026
Apr 6